Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

Patients with Crohn's disease experiencing endoscopic postoperative recurrence (POR) may benefit from antitumor necrosis factor (TNF) agents but scarce data on this are available. Our aim was to assess the efficacy of anti-TNF in improving mucosal lesions in patients with endoscopic POR. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Cañete, Fiorella, Mañosa, Míriam, Pérez-Martínez, Isabel, Barreiro-de Acosta, Manuel, González-Sueyro, Ramiro C., Nos, Pilar, Iglesias-Flores, Eva, Gutiérrez, Ana, Bujanda, Luis, Gordillo, Jordi, Ríos León, Raquel, Casanova, María José, Villoria, Albert, Rodríguez-Lago, Iago, López Serrano, Pilar, García-Herola, Antonio, Ramírez-de la Piscina, Patricia, Navarro-Llavat, Mercè, Taxonera, Carlos, Barrio, Jesús, Ramos, Laura, Navarro, Pablo, Benítez-Leiva, Olga, Calafat, Margalida, Domènech, Eugeni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431219/
https://www.ncbi.nlm.nih.gov/pubmed/32955190
http://dx.doi.org/10.14309/ctg.0000000000000218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431219/
https://www.ncbi.nlm.nih.gov/pubmed/32955190
http://dx.doi.org/10.14309/ctg.0000000000000218

Ejemplares similares